Adults on growth hormone treatment face increased diabetes risk

11/20/2011 | PhysiciansBriefing.com

A study in Diabetes Care revealed that receiving growth hormone replacement therapy in adulthood may elevate the risk of developing diabetes. Researchers studied 5,143 adults and found that 523 patients developed diabetes after six years of treatment. The patients who developed diabetes tended to be older, with higher blood pressure, waist circumference, body mass index and triglyceride concentrations than those who did not develop the disease.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY